Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 EX-1.1
- 2.1 EX-2.1
- 3.1 EX-3.1
- 3.4 EX-3.4
- 4.2 EX-4.2
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3A
- 10.3 EX-10.3B
- 10.3 EX-10.3C
- 10.4 EX-10.4A
- 10.4 EX-10.4B
- 10.5 EX-10.5A
- 10.5 EX-10.5B
- 10.6 EX-10.6(A)
- 10.6 EX-10.6(B)
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 21.1 EX-21.1
- 23.1 EX-23.1
- 23.2 EX-23.2
- 23.3 EX-23.3
Associated filings
RVMD similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the use in this Registration Statement onForm S-1 of Revolution Medicines, Inc. of our report dated October 16, 2018 relating to the financial statements of Warp Drive Bio, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
January 17, 2020